Doctor profile · Federal record
Dr. Mark Amster, MD
Dermatology Physician (CMS: Dermatology) · Brighton, MA
- NPI 1518947068
- Accepts Medicare
- 39 yrs in practice
- Male
- No sanctions
Practice & contact
- Primary practice
-
280 Washington St, Suite 212
Brighton, MA 021353511
(617) 783-7100 - Mailing address
-
18 Whispering Ln
Natick, MA 017605883
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Massachusetts #70448
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518947068. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,059
Distinct HCPCS
10
Medicare allowed
$372,908
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,212 | 536 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,282 | 984 | $95 | |
17000 |
Destruction of precancer skin growth, 1 growth | 952 | 684 | $58 | |
11102 |
Biopsy of related skin growth, first growth | 613 | 511 | $104 | |
11301 |
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 199 | 144 | $119 | |
11103 |
Biopsy of related skin growth, each additional growth | 190 | 141 | $55 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 131 | 131 | $117 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 120 | 112 | $60 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 96 | 84 | $189 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 65 | 56 | $184 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 300. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$10,227
Transactions
112
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Galderma Laboratories, L.P. | 15 | $8,173.65 | |
| UCB, Inc. | 19 | $348.01 | |
| E.R. Squibb & Sons, L.L.C. | 20 | $305.13 | |
| ABBVIE INC. | 19 | $281.94 | |
| Janssen Biotech, Inc. | 7 | $271.85 | |
| GENZYME CORPORATION | 6 | $171.97 | |
| Incyte Corporation | 8 | $135.90 | |
| PFIZER INC. | 4 | $86.92 | |
| LEO Pharma Inc. | 2 | $66.00 | |
| Lilly USA, LLC | 3 | $59.27 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55.87 | |
| Janssen Research & Development, LLC | 1 | $52.40 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $45.65 | |
| Organon Llc | 3 | $40.65 | |
| Amgen Inc. | 1 | $31.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
949
Patients
597
Total drug cost
$206,730
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 164 | 110 | $6,290 |
| Betamethasone Dipropionate | Generic | 136 | 98 | $6,865 |
| Clobetasol Propionate | Generic | 101 | 66 | $7,458 |
| Mupirocin | Generic | 80 | 55 | $717 |
| Ketoconazole | Generic | 72 | 41 | $2,052 |
| Fluorouracil | Generic | 64 | 54 | $4,982 |
| Metronidazole | Generic | 44 | 31 | $3,467 |
| Dupixent Pen (Dupilumab) | Brand | 43 | 0 | $162,859 |
| Triamcinolone Acetonide | Generic | 43 | 21 | $452 |
| Doxycycline Hyclate | Generic | 39 | 21 | $840 |
Frequently asked questions
What is Dr. Mark Amster's medical specialty?
Dr. Mark Amster practices Dermatology Physician in Brighton, MA.
Where does Dr. Mark Amster practice?
Dr. Mark Amster practices at 280 Washington St, Brighton, MA 021353511. Office phone: 6177837100.
What is Dr. Mark Amster's NPI?
Dr. Mark Amster's National Provider Identifier (NPI) is 1518947068, issued by NPPES.
Does Dr. Mark Amster accept Medicare assignment?
Yes. Dr. Mark Amster accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Amster commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.